BSN Capital Partners’s Johnson & Johnson JNJ Stock Holding History

BSN Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-90,000	Closed	-$13.2M	–	33
2024 Q3	$13.2M	Buy	+90,000	New	+$14.3M	2.58%	17

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BSN Capital Partners's JNJ Position: Q4 2024 in Review

BSN Capital Partners sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 90,000 shares — an estimated $13.2M sold.

BSN Capital Partners first reported a position in JNJ in Q3 2024 and held it in 1 quarter. The position peaked at $13.2M in Q3 2024. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

BSN Capital Partners reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
BSN Capital Partners sold 90,000 Johnson & Johnson shares in Q4 2024, an estimated $13.2M.
BSN Capital Partners first reported a position in Johnson & Johnson in Q3 2024 and held it in 1 quarter.
BSN Capital Partners's Johnson & Johnson position peaked at $13.2M in Q3 2024.
4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on BSN Capital Partners's 13F filing for Q4 2024, filed 28 Jan 2025.